USPTO serial 98219801
CELEST
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SEGAL, MOLLY DANIELA
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with CELEST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $474*
Plus Government fees of $375
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan M. Gelchinsky
Jonathan M. Gelchinsky Pierce Atwood LLP254 Commercial StreetPortland, ME 04101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acids and modified nucleic acids, namey, short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes | ACTIVE | — |
| 005 | Drug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds directed to lipid nanoparticles for the purpose of delivering pharmaceutical preparations to specific target tissue sites; drug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds and agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations; drug delivery agents consisting of pharmaceutical preparations and therapeutic agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations for RNA, gene therapy and mRNA regulation; drug delivery agents consisting of pharmaceutical and biological preparations for medical use that facilitate the release and delivery of a wide variety of pharmaceutical preparations for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; drug delivery agents consisting of pharmaceutical preparations that facilitate the release and delivery of a wide variety of pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation; pharmaceutical preparations, namely, vaccines | ACTIVE | — |
| 042 | Research and development in the field of technology and engineering, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, drug delivery agents and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, drug delivery agents and assays for use in pharmaceutical and biomedical industry | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ReNAgade Therapeutics Management, Inc.
- Other trademarks owned by ReNAgade Therapeutics Management, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CELEST
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 29, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 29, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 2, 2026 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jun 2, 2026 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jun 2, 2026 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jun 2, 2026 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| May 25, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 25, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 21, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 21, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 26, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 26, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 23, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 30, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 30, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 4, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 4, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 4, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 15, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 15, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 17, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 16, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 14, 2023 | NWAP | NEW APPLICATION ENTERED | — |